Amprion Newsroom
Recent media coverage and announcements.
Press Release
PR Newswire
Amprion Announces Presentation of Findings Related to Usage of the αSynuclein Seed Amplification Assay in Recent Parkinson's Study at 2023 AAN Annual Meeting
April 21, 2023
Read MorePress Release
PR Newswire
Amprion Announces Granting of European Patents for Seed Amplification Assay Platform
August 15, 2023
Read MorePress Release
Business Wire
Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics
October 9, 2024
Read MorePress Release
PR Newswire
Amprion Announces Collaboration with NIH Researchers on Dementia Hallmark Study
August 23, 2023
Read MorePress Release
PR Newswire
ALS Network Announces $100000 Research Grant Awarded to Amprion Inc.
September 12, 2024
Read MorePodcast
Neurology Live
Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test (Episode 132)
January 10, 2025
Read MorePodcast
Clinical Lab Chaat
Alpha-Synuclein: Adding Precision to Neurodegenerative Testing
January 6, 2025
Read MorePodcast
Life Sciences 360
How Amprion's Test is Changing ALS Dementia and Parkinson's Disease Diagnosis
September 24, 2024
Read MorePodcast
Life Science Success
Dr. Russ Lebovitz: Revolutionizing Brain Health with Early Detection
September 26, 2024
Read MoreNews Article
Los Angeles Times
Bioscience Firms in Southern California Focus on Innovation & Collaboration
May 18, 2025
Read MoreNews Article
Diagnostics World
Trendspotting: Predictions for Diagnostics World in 2025
January 7, 2025
Read MoreNews Article
Neurology Live
Feasibility and Scalability of Amprion's Assay for Synucleinopathy Diagnosis: Russ Lebovitz MD PhD
January 24, 2025
Read MoreNews Article
Medical Product Outsourcing
Getting to the Point of In-Vitro Diagnostics
April 29, 2025
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-ɑSYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
